维普中文期刊产品整合服务
意见 帮助
基本检索 作者索引 机构索引 期刊索引
  • 哲学宗教
  • 社会学
  • 政治法律
  • 军事
  • 经济管理
  • 文化科学
  • 语言文字
  • 文学
  • 艺术
  • 历史地理
  • 自然科学总论
  • 理学
  • 天文地球
  • 生物学
  • 医药卫生
  • 农业科学
  • 一般工业技术
  • 矿业工程
  • 石油与天然气工程
  • 冶金工程
  • 金属学及工艺
  • 机械工程
  • 兵器科学与技术
  • 动力工程及工程热...
  • 核科学技术
  • 电气工程
  • 电子电信
  • 自动化与计算机技术
  • 化学工程
  • 轻工技术与工程
  • 建筑科学
  • 水利工程
  • 交通运输工程
  • 航空宇航科学技术
  • 环境科学与工程
时间 1989 - 2010 学科选择学科
题名/关键词 模糊
与 题名/关键词 模糊
重新搜索 在结果中搜索
18篇 您的检索式：作者名="Trtimper L"
选中 清除  导出 查看参考文献 查看引证文献 引用追踪 共1页 首页 上一页 第1页 下一页 末页 /1 跳转
    题名 作者 年代 出处 被引量
1CHOP-like chem- otherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma:a randomised controlled trial by the MabThera International Trial (MINT) Group 显示文摘Pfreundsehuh M Trtimper L Osterborg A 2006Lancet Oncol2006，7，5：1
2Chemotherapy dose intensity in non- Hodgkin's lymphoma:is dose intensity an emerging paradigm for better outcomes? 显示文摘Gregory SA Trtimper L 2005AnnOncol2005，16，9：1
3Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group显示文摘Schmitz N Trtimper L Ziepert M 2010Blood2010，116，18：1
4Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good-prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL显示文摘Pfreundschuh M Trtimper L Kloess M 2004Blood2004，104，3：1
5CHOP- like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial(MinT)Group 显示文摘Pfreundschuh M Trtimper L Osterborg A 2006Lancet Oncol2006，7，5：1
6CHOP-like chemotherapy with or without rituximab in young patients with good-prognosis diffuse large-B-cell lymphoma: 6-year results of an open-label randomised study of the MabThera International Trial (MINT) Group 显示文摘Pfreundschuh M Kuhnt E Trtimper L 2011Lancet Oncol2011，12，11：1
7Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of elderly patients with aggressive lymphomas: results of the NHL-B2 trial of the DSHNHL显示文摘Pfreundschuh M Trtimper L - Schmits R 2004Blood2004，104，：1
8CHOP-like chemotherapy plus rituximab versus CHOP-like chemo- therapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MINT) Group 显示文摘Pfreundschuh M Trtimper L Osterborg A 2006Lancet Oncol2006，7，5：1
9CHOP- like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good progno- sis diffuse large B-cell lymphoma:a randomised con- trolled trial by the Mab Thera International Trial (MinT) Group显示文摘Pfreundschuh M Trtimper L Osterborg A 2006Lancet Oncol2006，7，：1
10CHOP-like chemotherapy with or without rituximab in young patients with goodprognosis diffuse large B-cell lymphoma:6- year results of an open-label randomised study of the MabThera International Trial (MinT) Group 显示文摘Pfreundschuh M Kuhnt E Trtimper L 2011Lancet Oncol2011，12，：1
11Treatment and progno- sis of mature T-cell and NK-cell lympboma: an analysis of pa- tients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group 显示文摘Schmitz N Trtimper L Ziepert M 2010Blood2010，116，18：1
12Two-weekly or 3- weekly CHOP chemotherapy with or without etoposide for thetreat- ment of young patients with good-prognosis ( normal LDH) aggres- sive lymphomas: results of the NHL-B1 trial of the DSHNHL显示文摘Pfreundschuh M Trtimper L Kloess M 2004Blood2004，104，3：1
13Treatment and prognosis of mature T-cell and NK--cell lymphoma:an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group 显示文摘Schmitz N Trtimper L Ziepert M 2010Blood2010，116，18：1
14CHOP-like c- hemotherapy with or without rituximab in young patients with goodprognosis diffuse large-B-cell lymphom :6-year re- suits of an openlabel randomised study of the mabthera in- ternational trial (mint) group 显示文摘Pfreundschuh M Kuhnt E Trtimper L 2011Lancet Oncol2011，12，11：1
15Two-weekly or 3-weekly CHOP chemotherapy with or without etoposide for the treatment of young patients with good prognosis (normal LDH) aggressive lymphomas: results of the NHL-B1 trial of the DSHNHL显示文摘Pfreundschuh M Trtimper L Kloess M 2004Blood2004，104，3：1
16CHOP- hke chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-progno- sis diffuse large-B-cell lymphoma: a randomised con- trolled trial by the MabThera International Trial (MINT) Group显示文摘Pfreundschuh M Trtimper L Osterborg A 2006Lancet Oncol2006，7，5：1
17Treatment and prognosis of mature T-cell and NK-cell lymphoma:an analysis of patients with T- cell lymphoma treated in studies of the German High-Grade Non- Hodgkin Lymphoma Study Group 显示文摘Schmitz N Trtimper L Ziepert M 2010Blood2010，116，18：1
18Chemotherapy dose Intensity in Non-Hodgkin's Lymphoma: is dose Intensity an Emerging Paradigm for Better Outcomes显示文摘Gregory S A Trtimper L 2005Ann Oncol2005，16，9：1
返回顶部 每页显示：
共1页 首页 上一页 第1页 下一页 末页 /1 跳转
goolge学术搜索-维普

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1　渝公网安备 50019002500403号　违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费